Mirae Asset Global Investments Co. Ltd. lessened its holdings in shares of NanoString Technologies, Inc. (NASDAQ:NSTG – Get Rating) by 15.6% in the 1st quarter, HoldingsChannel.com reports. The firm owned 141,847 shares of the biotechnology company’s stock after selling 26,207 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in NanoString Technologies were worth $4,930,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Advisor Group Holdings Inc. lifted its holdings in shares of NanoString Technologies by 15.0% during the 4th quarter. Advisor Group Holdings Inc. now owns 3,795 shares of the biotechnology company’s stock valued at $160,000 after purchasing an additional 496 shares during the last quarter. Commonwealth Equity Services LLC purchased a new position in NanoString Technologies in the 1st quarter worth $211,000. AlphaCrest Capital Management LLC purchased a new position in NanoString Technologies in the 1st quarter worth $267,000. SG3 Management LLC purchased a new position in NanoString Technologies in the 4th quarter worth $317,000. Finally, Ensign Peak Advisors Inc purchased a new position in NanoString Technologies in the 4th quarter worth $342,000.
Analysts Set New Price Targets
A number of equities analysts recently issued reports on the company. Cowen reduced their target price on NanoString Technologies to $31.00 in a research note on Tuesday, August 9th. Morgan Stanley reduced their target price on NanoString Technologies from $30.00 to $28.00 and set an “equal weight” rating for the company in a research note on Monday, August 8th. Finally, Robert W. Baird reduced their target price on NanoString Technologies from $30.00 to $21.00 in a research note on Friday, August 5th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $39.14.
NanoString Technologies Stock Performance
NanoString Technologies (NASDAQ:NSTG – Get Rating) last released its quarterly earnings data on Thursday, August 4th. The biotechnology company reported ($0.85) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.62) by ($0.23). The company had revenue of $32.22 million for the quarter, compared to analysts’ expectations of $32.32 million. NanoString Technologies had a negative net margin of 97.45% and a negative return on equity of 87.86%. The business’s quarterly revenue was down 4.9% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.60) EPS. On average, equities analysts forecast that NanoString Technologies, Inc. will post -2.55 earnings per share for the current year.
NanoString Technologies Profile
NanoString Technologies, Inc develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system.
- Get a free copy of the StockNews.com research report on NanoString Technologies (NSTG)
- What Steelcase’s Earnings Say About the Return to the Office?
- The Institutions Hold On To Darden Restaurants International
- Is The Golden Age Of Homebuilding Already Over?
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.